Dr Reddy's Labs, Sun Pharma recall products in American market over manufacturing issues Ruchika Sharma31 May 2024 12:11 PM ISTNew Delhi: Dr Reddy's Laboratories and Sun Pharma are recalling products in the American market following manufacturing concerns, as stated by...
Indian dugmakers to see revenue surge in key US market during FY25: India Ratings and Research Ruchika Sharma28 May 2024 11:30 AM ISTHyderabad: India Ratings and Research, headquartered in Mumbai, stated on Monday that Indian drugmakers, with a significant presence in the U.S....
Sun Pharma new plant inaugurated in Bangladesh Ruchika Sharma27 May 2024 2:50 PM ISTThis is the company's second investment in Bangladesh with a production capacity of over 1 billion tablets and capsules per year.
NPPA Fixes Retail Price Of 37 Formulations, Details Dr. Divya Colin24 May 2024 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 37 formulations under the...
Shareholders of Taro Pharma approve merger with Sun Pharma Ruchika Sharma24 May 2024 12:34 PM ISTMumbai: Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd have declared that the merger agreement between the two...
Sun Pharma, Dr Reddy's Labs, Aurobindo recall products in US over manufacturing issues Ruchika Sharma20 May 2024 12:50 PM ISTNew Delhi: According to the latest Enforcement Report from the US Food and Drug Administration (USFDA), pharmaceutical companies Dr Reddy's...
Dr Reddy's Labs expects strong product pipeline in North America for FY25 Ruchika Sharma9 May 2024 5:47 PM ISTBengaluru: Dr. Reddy's Laboratories, based in India, forecasts a strong product lineup for its key market in North America in the fiscal year...
Sun Pharma served with tax demand of Rs 1.11 crore Ruchika Sharma1 May 2024 1:20 PM ISTMumbai: Sun Pharmaceutical Industries has been served with a tax demand of over Rs 1.11 crore by authorities, citing disallowed input tax...
Trademark Tussle: HC bars Glenmark from using Indamet, says similar to Sun Pharma's anti-diabetes drug Istamet Farhat Nasim22 April 2024 2:44 PM ISTNew Delhi: In a major respite to Sun Pharma Laboratories Ltd. , the Delhi High Court has upheld its previous ruling from July, affirming the...
Sun Pharma receives OAI status from USFDA for Dadra facility Ruchika Sharma12 April 2024 11:42 AM ISTMumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study FDC of Relugolix, Estradiol, Norethindrone Acetate Dr. Divya Colin8 April 2024 6:00 PM ISTNew Delhi: Rejecting for clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Sun Pharma Industries Gets CDSCO Panel Nod To Manufacture Market Elagolix Tablets 150 mg,200 mg Dr. Divya Colin6 April 2024 6:00 PM ISTNew Delhi: With the condition to be sold by retail under the prescription of a Gynaecologist only, pharmaceutical major Sun Pharma Industries has got...
